Phosphatidylinositol-3-kinase in isolated rat adipocytes. Activation by insulin and subcellular distribution.

PubWeight™: 1.43‹?› | Rank: Top 5%

🔗 View Article (PMID 1310686)

Published in J Biol Chem on February 15, 1992

Authors

K L Kelly1, N B Ruderman, K S Chen

Author Affiliations

1: Boston University Medical Center, Division of Diabetes and Metabolism, Massachusetts 02118-2393.

Articles citing this

Phosphatidylinositol 3'-kinase is activated by association with IRS-1 during insulin stimulation. EMBO J (1992) 5.84

Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling. Biochem J (1998) 3.94

A membrane-associated complex containing the Vps15 protein kinase and the Vps34 PI 3-kinase is essential for protein sorting to the yeast lysosome-like vacuole. EMBO J (1993) 3.49

Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J Clin Invest (1995) 2.66

The v-Src SH3 domain binds phosphatidylinositol 3'-kinase. Mol Cell Biol (1993) 1.96

Chromaffin granule-associated phosphatidylinositol 4-kinase activity is required for stimulated secretion. EMBO J (1996) 1.76

Defect in skeletal muscle phosphatidylinositol-3-kinase in obese insulin-resistant mice. J Clin Invest (1993) 1.62

Modulation of insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle of dexamethasone-treated rats. J Clin Invest (1993) 1.61

Internalization of activated platelet-derived growth factor receptor-phosphatidylinositol-3' kinase complexes: potential interactions with the microtubule cytoskeleton. Mol Cell Biol (1993) 1.43

Activation of pp70/85 S6 kinases in interleukin-2-responsive lymphoid cells is mediated by phosphatidylinositol 3-kinase and inhibited by cyclic AMP. Mol Cell Biol (1995) 1.42

Intracellular localization of phosphatidylinositide 3-kinase and insulin receptor substrate-1 in adipocytes: potential involvement of a membrane skeleton. J Cell Biol (1998) 1.41

Regulation of phosphatidylinositol 3-kinase activity in liver and muscle of animal models of insulin-resistant and insulin-deficient diabetes mellitus. J Clin Invest (1993) 1.36

Gapex-5, a Rab31 guanine nucleotide exchange factor that regulates Glut4 trafficking in adipocytes. Cell Metab (2007) 1.35

Phosphatidylinositol (PI) 3-kinase and PI 4-kinase binding to the CD4-p56lck complex: the p56lck SH3 domain binds to PI 3-kinase but not PI 4-kinase. Mol Cell Biol (1993) 1.34

A phosphatidylinositol 3-kinase is induced during soybean nodule organogenesis and is associated with membrane proliferation. Proc Natl Acad Sci U S A (1994) 1.23

The ras signaling pathway mimics insulin action on glucose transporter translocation. Proc Natl Acad Sci U S A (1993) 1.20

The TC10-interacting protein CIP4/2 is required for insulin-stimulated Glut4 translocation in 3T3L1 adipocytes. Proc Natl Acad Sci U S A (2002) 1.12

Insulin-mediated inhibition of apolipoprotein B secretion requires an intracellular trafficking event and phosphatidylinositol 3-kinase activation: studies with brefeldin A and wortmannin in primary cultures of rat hepatocytes. Biochem J (1996) 1.07

Biochemical and pharmacological studies with KT7692 and LY294002 on the role of phosphatidylinositol 3-kinase in Fc epsilon RI-mediated signal transduction. Biochem J (1995) 1.06

Discrimination of GLUT4 vesicle trafficking from fusion using a temperature-sensitive Munc18c mutant. EMBO J (2000) 0.93

Specific activity of phosphatidylinositol 3-kinase is increased by insulin stimulation. Biochem J (1993) 0.79

Association of the insulin receptor and phosphatidylinositol 3-kinase requires a third component. Biochem J (1994) 0.76

Articles by these authors

Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood (2001) 5.23

Molecular mechanism for duplication 17p11.2- the homologous recombination reciprocal of the Smith-Magenis microdeletion. Nat Genet (2000) 3.80

A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease. Nature (2001) 3.28

Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons. Cell (1994) 2.88

BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics. Hum Mol Genet (2001) 2.76

The "metabolically-obese," normal-weight individual. Am J Clin Nutr (1981) 2.71

Evaluation of the isolated perfused rat hindquarter for the study of muscle metabolism. Biochem J (1971) 2.66

Electron microscopic and biochemical study of lipoprotein synthesis in the isolated perfused rat liver. J Lipid Res (1967) 2.58

Contraction-induced changes in acetyl-CoA carboxylase and 5'-AMP-activated kinase in skeletal muscle. J Biol Chem (1997) 2.54

Muscle glucose metabolism following exercise in the rat: increased sensitivity to insulin. J Clin Invest (1982) 2.41

The phosphatidylinositol 3-kinase serine kinase phosphorylates IRS-1. Stimulation by insulin and inhibition by Wortmannin. J Biol Chem (1994) 2.09

Glucose metabolism in perfused skeletal muscle. Effects of starvation, diabetes, fatty acids, acetoacetate, insulin and exercise on glucose uptake and disposition. Biochem J (1976) 1.90

The formation of glutamine and alanine in skeletal muscle. J Biol Chem (1974) 1.90

Insulin-stimulated phosphatidylinositol 3-kinase. Association with a 185-kDa tyrosine-phosphorylated protein (IRS-1) and localization in a low density membrane vesicle. J Biol Chem (1993) 1.88

Regulation of glucose and ketone-body metabolism in brain of anaesthetized rats. Biochem J (1974) 1.78

Glucose metabolism in perfused skeletal muscle. Interaction of insulin and exercise on glucose uptake. Biochem J (1975) 1.71

Effect of acetoacetate on glucose metabolism in the soleus and extensor digitorum longus muscles of the rat. Biochem J (1977) 1.69

A role for malonyl-CoA in glucose-stimulated insulin secretion from clonal pancreatic beta-cells. J Biol Chem (1989) 1.67

Evidence that lysosomes are not involved in the degradation of myofibrillar proteins in rat skeletal muscle. Biochem J (1986) 1.66

Novel mutations of MYO15A associated with profound deafness in consanguineous families and moderately severe hearing loss in a patient with Smith-Magenis syndrome. Hum Genet (2001) 1.66

Glucose regulation of hepatic gluconeogenesis. Am J Physiol (1968) 1.64

Role of free fatty acids in glucose homeostasis. Arch Intern Med (1969) 1.61

Muscle amino acid metabolism and gluconeogenesis. Annu Rev Med (1975) 1.61

Glucose metabolism in rat skeletal muscle at rest. Effect of starvation, diabetes, ketone bodies and free fatty acids. Diabetes (1974) 1.61

Behavioral phenotypes of amyloid-based genetically modified mouse models of Alzheimer's disease. Genes Brain Behav (2005) 1.58

Clinical correlates of antifungal macrodilution susceptibility test results for non-AIDS patients with severe Candida infections treated with fluconazole. Antimicrob Agents Chemother (2000) 1.57

Acetoacetate as a fuel for perfused rat skeletal muscle. Biochem J (1971) 1.54

Starvation in the rat. II. Effect of age and obesity on protein sparing and fuel metabolism. Am J Physiol (1980) 1.43

Muscle glycogenolysis during exercise: dual control by epinephrine and contractions. Am J Physiol (1982) 1.40

Leptinomimetic effects of the AMP kinase activator AICAR in leptin-resistant rats: prevention of diabetes and ectopic lipid deposition. Diabetologia (2004) 1.40

Insulin binding and sensitivity in rat skeletal muscle: effect of starvation. Am J Physiol (1981) 1.39

Diabetes as an atherogenic factor. Prog Cardiovasc Dis (1984) 1.35

Diabetes and exercise. Am J Med (1981) 1.33

Diet-induced muscle insulin resistance in rats is ameliorated by acute dietary lipid withdrawal or a single bout of exercise: parallel relationship between insulin stimulation of glucose uptake and suppression of long-chain fatty acyl-CoA. Diabetes (1997) 1.33

An electron microscopic study of lipoprotein production and release by the isolated perfused rat liver. Proc Soc Exp Biol Med (1966) 1.33

Activation of malonyl-CoA decarboxylase in rat skeletal muscle by contraction and the AMP-activated protein kinase activator 5-aminoimidazole-4-carboxamide-1-beta -D-ribofuranoside. J Biol Chem (2000) 1.31

Human amnesia and animal models of amnesia: performance of amnesic patients on tests designed for the monkey. Behav Neurosci (1988) 1.30

Starvation in the rat. I. Effect of age and obesity on organ weights, RNA, DNA, and protein. Am J Physiol (1980) 1.29

DNA rearrangements on both homologues of chromosome 17 in a mildly delayed individual with a family history of autosomal dominant carpal tunnel syndrome. Am J Hum Genet (1999) 1.28

Adaptation to prolonged starvation in the rat: curtailment of skeletal muscle proteolysis. Am J Physiol (1981) 1.25

Pulmonary actinomycosis appearing as a "ball-in-hole" on chest radiography and bronchoscopy. Thorax (1996) 1.24

Enhanced muscle glucose metabolism after exercise: modulation by local factors. Am J Physiol (1984) 1.24

Glucose and amino acid metabolism in perfused skeletal muscle. Effect of dichloroacetate. Diabetes (1978) 1.21

Synthesis of essential amino acids from their alpha-keto analogues by perfused rat liver and muscle. J Clin Invest (1973) 1.21

Progressive decline in spatial learning and integrity of forebrain cholinergic neurons in rats during aging. Neurobiol Aging (1992) 1.17

Muscle lipid accumulation and protein kinase C activation in the insulin-resistant chronically glucose-infused rat. Am J Physiol (1999) 1.15

Stimulation of vascular Na(+)-K(+)-ATPase activity by nitric oxide: a cGMP-independent effect. Am J Physiol (1994) 1.14

Enhanced muscle glucose metabolism after exercise in the rat: the two phases. Am J Physiol (1984) 1.14

Effects of starvation and exercise on concentrations of citrate, hexose phosphates and glycogen in skeletal muscle and heart. Evidence for selective operation of the glucose-fatty acid cycle. Biochem J (1985) 1.13

Studies on the mechanism of improved glucose control during regular exercise in type 2 (non-insulin-dependent) diabetes. Diabetologia (1984) 1.13

Malonyl-CoA content and fatty acid oxidation in rat muscle and liver in vivo. Am J Physiol Endocrinol Metab (2000) 1.12

Regulation of fatty acid oxidation and glucose metabolism in rat soleus muscle: effects of AICAR. Am J Physiol Endocrinol Metab (2001) 1.10

Permeation behavior of salbutamol sulfate through hydrophilic and hydrophobic membranes embedded by thermo-responsive cholesteryl oleyl carbonate. Pharm Res (1996) 1.09

Chronic hypoglycemia increases brain glucose transport. Am J Physiol (1986) 1.07

Thermal decomposition and reconstitution of hydroxyapatite in air atmosphere. Biomaterials (1999) 1.07

The effect of physical training on glucose tolerance and plasma lipids in maturity-onset diabetes. Diabetes (1979) 1.07

A malonyl-CoA fuel-sensing mechanism in muscle: effects of insulin, glucose, and denervation. Am J Physiol (1995) 1.07

A digoxin-like immunoreactive substance and atrioventricular block induced by a Chinese medicine "kyushin". Jpn Circ J (1989) 1.07

Regulation of production and release of lipoprotein by the perfused rat liver. J Lipid Res (1968) 1.06

Insulin sensitivity of rat skeletal muscle: effects of starvation and aging. Am J Physiol (1979) 1.06

Hyperglycemia inhibits insulin activation of Akt/protein kinase B but not phosphatidylinositol 3-kinase in rat skeletal muscle. Diabetes (1999) 1.06

The regulation of gluconeogenesis. The effect of pent-4-enoic acid on gluconeogenesis and on the gluconeogenic metabolite concentrations of isolated perfused rat liver. J Biol Chem (1970) 1.06

Sites of protein conservation and loss during starvation: influence of adiposity. Am J Physiol (1984) 1.04

Muscle alpha-aminoisobutyric acid transport after exercise: enhanced stimulation by insulin. Am J Physiol (1985) 1.04

Oxygen consumption in perfused skeletal muscle. Effect of perfusion with aged, fresh and aged-rejuvenated erythrocytes on oxygen consumption, tissue metabolites and inhibition of glucose utilization by acetoacetate. Biochem J (1980) 1.04

Effect of exercise on insulin receptor binding and kinase activity in skeletal muscle. Am J Physiol (1989) 1.03

Linked oscillations of free Ca2+ and the ATP/ADP ratio in permeabilized RINm5F insulinoma cells supplemented with a glycolyzing cell-free muscle extract. J Biol Chem (1988) 1.03

Mutations in the juxtamembrane region of the insulin receptor impair activation of phosphatidylinositol 3-kinase by insulin. Mol Endocrinol (1991) 1.02

Fluconazole disk diffusion test with methylene blue- and glucose-enriched Mueller-Hinton agar for determining susceptibility of Candida species. J Clin Microbiol (2001) 1.02

NGF induction of NGF receptor gene expression and cholinergic neuronal hypertrophy within the basal forebrain of the adult rat. Neuron (1989) 1.02

Malonyl-CoA regulation in skeletal muscle: its link to cell citrate and the glucose-fatty acid cycle. Am J Physiol (1997) 1.00

Active synthesis of hemagglutinin-specific immunoglobulin A by lung cells of mice that were immunized intragastrically with inactivated influenza virus vaccine. J Virol (1987) 1.00

Experimental approaches to age-related cognitive impairments. Neurobiol Aging (1989) 1.00

Glucose uptake and insulin sensitivity in rat muscle: changes during 3-96 weeks of age. Am J Physiol (1983) 0.99

pH of preparations affecting the on-off drug penetration behavior through the thermo-responsive liquid crystal-embedded membrane. J Control Release (1998) 0.99

A theoretical investigation on the sequence selective binding of adriamycin to double-stranded polynucleotides. Nucleic Acids Res (1986) 0.98

Regulation of ketone body metabolism in skeletal muscle. Am J Physiol (1973) 0.98

NGF receptor reexpression and NGF-mediated cholinergic neuronal hypertrophy in the damaged adult neostriatum. Neuron (1989) 0.97

Cytosolic citrate and malonyl-CoA regulation in rat muscle in vivo. Am J Physiol (1999) 0.97

Ten-year experience with an exercise-based outpatient life-style modification program in the treatment of diabetes mellitus. Diabetes Care (1992) 0.96

The cardiovascular, pulmonary, and ocular hypotensive effects of 0.2% brimonidine. Arch Ophthalmol (1995) 0.96

A biochemical and morphologic study of very low density lipoproteins in carbohydrate-induced hypertriglyceridemia. J Clin Invest (1971) 0.95

Muscle nitrogen metabolism in chronic hepatic insufficiency. Metabolism (1976) 0.95

Endothelium-dependent inhibition of Na(+)-K+ ATPase activity in rabbit aorta by hyperglycemia. Possible role of endothelium-derived nitric oxide. J Clin Invest (1992) 0.95

Sequence and expression of the Escherichia coli recR locus. J Bacteriol (1990) 0.95

Morphologic alterations of choline acetyltransferase-positive neurons in the basal forebrain of aged behaviorally characterized Fisher 344 rats. Neurobiol Aging (1994) 0.94

Inhibition of hepatic gluconeogenesis and fatty acid oxidation by pent-4-enoic acid. Am J Physiol (1970) 0.94

Cloning, genomic structure, and expression of mouse ring finger protein gene Znf179. Genomics (1998) 0.93

Subunit 3 of the COP9 signal transduction complex is conserved from plants to humans and maps within the smith-magenis syndrome critical region in 17p11.2. Genomics (1999) 0.93

Multiple requirements for glycogen synthesis by hepatocytes isolated from fasted rats. J Biol Chem (1985) 0.93

Genomic structure, evolution, and expression of human FLII, a gelsolin and leucine-rich-repeat family member: overlap with LLGL. Genomics (1997) 0.92

Regulation of myofibrillar protein degradation in rat skeletal muscle during brief and prolonged starvation. Metabolism (1986) 0.92

Amino acid metabolism in skeletal muscle. Regulation of glutamine and alanine release in the perfused rat hindquarter. Isr J Med Sci (1972) 0.92

Video-assisted laparoscopic procedures in peritoneal dialysis. Surg Endosc (2003) 0.91

Degradation behaviour of a new bioceramic: Ca2P2O7 with addition of Na4P2O7.10H2O. Biomaterials (1997) 0.91

Two new natural azafluorene alkaloids and a cytotoxic aporphine alkaloid from Polyalthia longifolia. J Nat Prod (1991) 0.91

A physical map of the mouse shaker-2 region contains many of the genes commonly deleted in Smith-Magenis syndrome (del17p11.2p11.2). Genomics (1999) 0.91

Prophylactic treatment of intraocular pressure elevations after neodymium: YAG laser posterior capsulotomies and extracapsular cataract extractions with levobunolol. Ophthalmology (1988) 0.90

Alteration in the expression of GLUT-1 and GLUT-4 protein and messenger RNA levels in denervated rat muscles. Endocrinology (1992) 0.90